AQR Capital Management
PYXS icon

AQR Capital Management’s Pyxis Oncology PYXS Stock Holding History

AQR Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,832
Closed -$30.7K – 3630
2025
Q3 		$30.7K Sell
13,832
-72,931
-84% -$105K ﹤0.01% 3439
2025
Q2 		$95.4K Buy
86,763
+46,493
+115% +$52.4K ﹤0.01% 3185
2025
Q1 		$39.5K Sell
40,270
-9,810
-20% -$13.1K ﹤0.01% 3097
2024
Q4 		$78.1K Buy
+50,080
New +$144K ﹤0.01% 2786

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management's PYXS Position: Q4 2025 in Review

AQR Capital Management sold out of Pyxis Oncology (PYXS) in Q4 2025, closing a stake of 13,832 shares — an estimated $30.7K sold.

AQR Capital Management first reported a position in PYXS in Q4 2024 and held it in 4 quarters. The position peaked at $95.4K in Q2 2025. 79 funds tracked by Wall St. Rank hold PYXS as of Q4 2025.

  • AQR Capital Management reported no remaining Pyxis Oncology position as of Q4 2025 after selling out during the quarter.
  • AQR Capital Management sold 13,832 Pyxis Oncology shares in Q4 2025, an estimated $30.7K.
  • AQR Capital Management first reported a position in Pyxis Oncology in Q4 2024 and held it in 4 quarters.
  • AQR Capital Management's Pyxis Oncology position peaked at $95.4K in Q2 2025.
  • 79 funds tracked by Wall St. Rank held Pyxis Oncology as of Q4 2025.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.